ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,508Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 625

$875K Total Retail Price of All Prescriptions

Rank: 44 out of 625

656 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 656 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 656 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

0% of this provider’s 10,079 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
PRAVASTATIN SODIUM 990 749 1 8
LISINOPRIL 918 602 2 5
AMLODIPINE BESYLATE 799 632 3 1
ALENDRONATE SODIUM 643 473 4 34
CARVEDILOL 583 384 5 23
GLIPIZIDE 455 375 6 56
METOPROLOL TARTRATE 400 252 7 11
DIOVAN 399 298 8 28
CLOPIDOGREL 356 283 9 30
CRESTOR 325 197 10 17
FAMOTIDINE 318 239 11 73
HYDROCHLOROTHIAZIDE 314 237 12 12
HYDRALAZINE HCL 289 230 13 80
ATORVASTATIN CALCIUM 272 180 14 9
PLAVIX 267 203 15 43
FLUTICASONE PROPIONATE 264 149 16 32
FUROSEMIDE 243 185 17 7
METOPROLOL SUCCINATE 235 132 18 15
METFORMIN HCL 225 154 19 10
LEVOTHYROXINE SODIUM 193 119 20 3
JANUVIA 164 97 21 74
ALLOPURINOL 163 147 22 29
ENALAPRIL MALEATE 161 71 23 81
ADVAIR DISKUS 160 82 24 63
TORSEMIDE 149 118 25 99
AMLODIPINE BESYLATE-BENAZEPRIL 147 112 26 48
PROAIR HFA 132 75 27 57
DIOVAN HCT 131 103 28 52
HYDROCODONE-ACETAMINOPHEN 122 63 S3 29 4
TRIAMTERENE-HCTZ 114 76 30 53
GABAPENTIN 110 61 31 14
ISOSORBIDE MONONITRATE ER 105 78 32 49
NASONEX 104 77 33 220
NEXIUM 92 49 34 21
OMEPRAZOLE 91 57 35 6
VENTOLIN HFA 91 42 35 93
SERTRALINE HCL 90 59 37 26
TERAZOSIN HCL 88 65 38 149
LABETALOL HCL 72 63 39 169
BENAZEPRIL HCL 69 49 40 35
JANUMET 68 32 41 163
INSULIN SYRINGE 68 35 41 77
PREDNISONE 63 38 43 37
LIPITOR 62 37 44 75
LEVEMIR FLEXPEN 61 42 45 142
CLONIDINE HCL 61 35 45 50
NOVOLOG FLEXPEN 59 46 47 151
TAMSULOSIN HCL 57 55 48 36
OXYCODONE-ACETAMINOPHEN 53 34 S2 49 95
GLIPIZIDE XL 50 42 50 83
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.